Immunohistochemical Differentiation of Triple Negative Breast Cancer

Based on immunohistochemical staining for the basal markers cytokeratin 5/6 (CK 5/6), cytokeratin 14 (CK 14) and P-cadherin, triple negative tumors (TNT) are divided into two groups: 1) basal-like (BL) positive for one or all three markers; and 2) non basal-like (NBL) negative for all three markers...

Full description

Bibliographic Details
Main Authors: Miroslav Lesar, Mladen Stanec, Nikola Lesar, Danko Velimir Vrdoljak, Zvonimir Zore, Marija Banović, Gordana Brozović
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2016-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:https://hrcak.srce.hr/file/237717
_version_ 1827283133733535744
author Miroslav Lesar
Mladen Stanec
Nikola Lesar
Danko Velimir Vrdoljak
Zvonimir Zore
Marija Banović
Gordana Brozović
author_facet Miroslav Lesar
Mladen Stanec
Nikola Lesar
Danko Velimir Vrdoljak
Zvonimir Zore
Marija Banović
Gordana Brozović
author_sort Miroslav Lesar
collection DOAJ
description Based on immunohistochemical staining for the basal markers cytokeratin 5/6 (CK 5/6), cytokeratin 14 (CK 14) and P-cadherin, triple negative tumors (TNT) are divided into two groups: 1) basal-like (BL) positive for one or all three markers; and 2) non basal-like (NBL) negative for all three markers. Even though the different origin of the cells of these two types of tumors implies different biological properties, they had been treated as one entity until recently. This paper analyzes TNT collected from 150 patients and distributed into two groups according to the results of immunohistochemical analysis, i.e. BL 116 (77.3%) and NBL 34 (22.67%). In this study, CK 5/6, CK 14 and P-cadherin were used as markers for identifying BL tumors. The immunohistochemical reaction was positive for CK 5/6 in 37%, for CK 14 in 50.86% and for P-cadherin in 68.34% of cases. The subclassification of triple negative breast cancer using the basal markers CK 5/6, CK 14 and P-cadherin has enabled identification of BL and NBL breast cancers in a proportion that is in line with the only accurate analysis of TNT gene expression. Using the mentioned combination of markers in daily practice is easy to perform and economically affordable.
first_indexed 2024-04-24T09:30:40Z
format Article
id doaj.art-22e5495fb96a4177b42906ff8733941a
institution Directory Open Access Journal
issn 0353-9466
1333-9451
language English
last_indexed 2024-04-24T09:30:40Z
publishDate 2016-01-01
publisher Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
record_format Article
series Acta Clinica Croatica
spelling doaj.art-22e5495fb96a4177b42906ff8733941a2024-04-15T13:53:26ZengSestre Milosrdnice University hospital, Institute of Clinical Medical ResearchActa Clinica Croatica0353-94661333-94512016-01-0155.1.3810.20471/acc.2016.55.01.1Immunohistochemical Differentiation of Triple Negative Breast CancerMiroslav Lesar0Mladen Stanec1Nikola Lesar2Danko Velimir Vrdoljak3Zvonimir Zore4Marija Banović5Gordana Brozović6Department of Oncology Surgery,University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Oncology and Plastic Surgery, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Anesthesiology,University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zaqgreb, CroatiaDepartment of Oncology Surgery, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Oncology Surgery,University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia,student, School of Medicine, University of Zagreb, Zagreb, CroatiaDepartment of Anesthesiology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; Faculty of Medicine, University of Osijek, Osijek, CroatiaBased on immunohistochemical staining for the basal markers cytokeratin 5/6 (CK 5/6), cytokeratin 14 (CK 14) and P-cadherin, triple negative tumors (TNT) are divided into two groups: 1) basal-like (BL) positive for one or all three markers; and 2) non basal-like (NBL) negative for all three markers. Even though the different origin of the cells of these two types of tumors implies different biological properties, they had been treated as one entity until recently. This paper analyzes TNT collected from 150 patients and distributed into two groups according to the results of immunohistochemical analysis, i.e. BL 116 (77.3%) and NBL 34 (22.67%). In this study, CK 5/6, CK 14 and P-cadherin were used as markers for identifying BL tumors. The immunohistochemical reaction was positive for CK 5/6 in 37%, for CK 14 in 50.86% and for P-cadherin in 68.34% of cases. The subclassification of triple negative breast cancer using the basal markers CK 5/6, CK 14 and P-cadherin has enabled identification of BL and NBL breast cancers in a proportion that is in line with the only accurate analysis of TNT gene expression. Using the mentioned combination of markers in daily practice is easy to perform and economically affordable.https://hrcak.srce.hr/file/237717Carcinoma, ductal, breastTriple negative breast neoplasmsBiomarkers, tumorBasallike tumorsNon basal-like tumorsAdult
spellingShingle Miroslav Lesar
Mladen Stanec
Nikola Lesar
Danko Velimir Vrdoljak
Zvonimir Zore
Marija Banović
Gordana Brozović
Immunohistochemical Differentiation of Triple Negative Breast Cancer
Acta Clinica Croatica
Carcinoma, ductal, breast
Triple negative breast neoplasms
Biomarkers, tumor
Basallike tumors
Non basal-like tumors
Adult
title Immunohistochemical Differentiation of Triple Negative Breast Cancer
title_full Immunohistochemical Differentiation of Triple Negative Breast Cancer
title_fullStr Immunohistochemical Differentiation of Triple Negative Breast Cancer
title_full_unstemmed Immunohistochemical Differentiation of Triple Negative Breast Cancer
title_short Immunohistochemical Differentiation of Triple Negative Breast Cancer
title_sort immunohistochemical differentiation of triple negative breast cancer
topic Carcinoma, ductal, breast
Triple negative breast neoplasms
Biomarkers, tumor
Basallike tumors
Non basal-like tumors
Adult
url https://hrcak.srce.hr/file/237717
work_keys_str_mv AT miroslavlesar immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT mladenstanec immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT nikolalesar immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT dankovelimirvrdoljak immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT zvonimirzore immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT marijabanovic immunohistochemicaldifferentiationoftriplenegativebreastcancer
AT gordanabrozovic immunohistochemicaldifferentiationoftriplenegativebreastcancer